Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDR1 | Q08345 | 5/20 | 0.33 |
| ▸ | SDHB | P21912 | 2/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 2/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22419059 | 0.93 | DDR1 (0.33) | DDR1SDHBPDE10AS1PR1GRM2 | |
| SCHEMBL22280382 | 0.87 | SMN1; SMN2 (0.37) | DDR1EGLN1 | |
| SCHEMBL20455829 | 0.85 | SMN1; SMN2 (0.35) | DDR1 | |
| SCHEMBL21805954 | 0.82 | HSD17B10 (0.34) | — | |
| SCHEMBL20465863 | 0.80 | — | — | |
| SCHEMBL20468526 | 0.79 | ALDH1A1 (0.32) | DDR1 | |
| SCHEMBL20465929 | 0.76 | PDE10A (0.32) | PDE10A | |
| SCHEMBL18015922 | 0.75 | PDE10A (0.35) | DDR1PDE10AS1PR1EGLN1 | |
| SCHEMBL18357972 | 0.75 | DDR1 (0.35) | DDR1PDE10AEGLN1 | |
| SCHEMBL20687612 | 0.74 | S1PR1 (0.37) | DDR1SDHBPDE10AELANES1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200236940-A1 | 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200236940-A1 | 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES | CYP4X1, CYP1A1, CYP1A2 | DDR1 2858/4885SDHB 3386/4885PDE10A 1669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.